[Hinews] SEOUL, South Korea — Hanyang University Hospital has earned a Grade 1 rating in the 2023 breast cancer care assessment by South Korea’s Health Insurance Review and Assessment Service (HIRA). The hospital recorded a composite score of 94.39, outperforming the average for tertiary general hospitals (93.75) and the national average (88.13).

Hanyang University Hospital exterior (Provided by Hanyang University Hospital)
Hanyang University Hospital exterior (Provided by Hanyang University Hospital)


The year-long evaluation, spanning January to December 2023, scrutinized the quality of breast cancer care across South Korean medical institutions. It focused on critical metrics, including the composition of specialized medical personnel, the thoroughness of pathology reports, and the frequency of radiation therapy post-mastectomy. Hanyang University Hospital secured perfect scores in these areas and excelled in other measures, such as the rate of multidisciplinary care.

“This recognition underscores our medical team’s dedication to delivering personalized care for every patient,” said Dr. Hyung-Joong Lee, president of Hanyang University Hospital. “We remain committed to enhancing our multidisciplinary framework and specialized care to elevate treatment outcomes and patients’ quality of life.”
Detailed results are available on the HIRA website.

키워드

#한양대학교병원#유방암적정성평가
저작권자 © Hinews 무단전재 및 재배포 금지
ad